Press release Read more about Poxel Announces Publication of Positive Phase 2 Results from Phase 2 NASH Trial (DESTINY-1) for PXL065 in Journal of Hepatology
Press release Read more about Mutares has successfully sold its portfolio company Lacroix + Kress GmbH to Superior Essex
Press release Read more about Cambi’s quarterly results show a record-high order intake and accelerated project execution. A dividend of NOK 0.15 per share is announced